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Abstract The conventional view that neuroinflammatory
lesions contain strictly pro- and anti-inflammatory cytoki-
nes is being challenged. Some proinflammatory products
e.g. TNF-a are crucial intermediates in axon regeneration,
oligodendroglial renewal and remyelination. A more
functional system of nomenclature classifies cytokines by
their neuro ‘protective’ or ‘suppressive’ properties. Beyond
the balance of these ‘environmental’ or ‘extrinsic’ signals,
specific ‘intrinsic’ determinants of cytokine signalling
appear to influence the outcome of axoglial regeneration.
In this commentary, we examine the potential importance
of cytokine-induced histone modification on oligodendro-
cyte differentiation. Neuroinflammation mediates the
release of astrocytic leukaemia inhibitory factor (LIF) and
erythropoietin (EPO) which potentiates oligodendrocyte
differentiation and myelin production. Meanwhile, histone
deacetylation strongly suppresses important inhibitors of
oligodendrocyte differentiation. Given that LIF and EPO
induce histone deacetylases in other systems, future studies
should examine whether this mechanism significantly
influences the outcome of cytokine-induced remyelination,
and whether epigenetic drug targets could potentiate the
effects of exogenous cytokine therapy.
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Abbreviations
TNF-a Tumour necrosis factor-alpha
LIF Leukaemia inhibitory factor
EPO Erythropoietin
HDACs Histone deacetylases
CNS Central nervous system
HATs Histone acetyltransferases
PDGFRA Platelet derived growth factor receptor alpha
OLIG2 Oligodendrocyte transcription factor 2
Jak Janus kinase
STAT3 Signal transducer and activator of transcription
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Background
Oligodendrocyte proliferation and differentiation is regu-
lated by an intricate network of extrinsic signals and
intrinsic genetic and epigenetic control mechanisms. These
are in turn determined by the dynamic milieu of the central
nervous system (CNS). Amongst an array of important
extracellular signals, astrocytes release leukaemia inhibi-
tory factor (LIF) and erythropoietin (EPO) which are
neuroprotective cytokines that promote the differentiation
of OLs and preserve the integrity of the myelin sheath
(Ishibashi et al. 2006, 2009; Cervellini et al. 2013). In the
‘steady state’, neuronal depolarisation releases adenosine
which stimulates the production of these cytokines (Ishi-
bashi et al. 2006). This process amplifies during episodes
of ‘axoglial stress’, e.g. following excitotoxicity or when
TNF-a is produced by inflammatory infiltrates (Fischer
et al. 2014; Moidunny et al. 2012). Previously, we dis-
cussed potential genetic elements that may influence the
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efficacy of exogenous cytokine therapy (Roe 2015). Sur-
prisingly, the literature paid little attention to the interac-
tions between cytokine signalling and mediators of
epigenetic modification.
Epigenetic modifications are defined as ‘‘heritable alter-
ations to the DNA architecture that do not change the
nitrogenous base sequence’’. The ‘epigenome’ describes a
landscape of chemical modifications affecting the histone
proteins that wrap DNA (histone acetylation and methy-
lation), or more directly, the DNA itself (DNA methyla-
tion). Previous studies have shown that the process of
(re)myelination is dependent on a variety of epigenetic
remodelling mechanisms including histone modification,
DNA methylation and miRNAs (Shen et al. 2005, 2008;
Liu and Casaccia 2010). In this commentary, we explore
the role of histone modification on oligodendrocyte dif-
ferentiation, the potential for neurotrophic cytokines to
induce these modifications and the scope for novel thera-
peutic targets to bolster remyelination in the context of
neuroinflammatory disease.
Commentary
The conformational structure of chromatin determines the
accessibility of genes. Acetylation of histone ‘tails’ reduces
the positive charge that compresses the chromatin structure
(Fig. 1). These modifications are determined by two key
enzyme families; histone acetyltransferases (HATs) which
acetylate histones and HDACs which remove the acetyl
groups. The latter increases the electrostatic interaction to
compress chromatin and hide regulatory gene elements.
HDACs and HATs also (de)acetylate and physically
interact with other nuclear proteins to form large tran-
scriptional complexes that directly regulate gene
expression.
In primary mouse oligodendrocyte progenitor cells, the
capacity for myelination correlates directly with the
activity of HDACs (Shen et al. 2008). Ye et al. found that
HDAC1/HDAC2-/- mice developed severe tremors and
died at postnatal day 14 (Ye et al. 2009). Oligodendrocyte
progenitor-specific markers PDGFRA and OLIG2 were
Fig. 1 Proposed schematic of LIF-induced epigenetic ‘de-repression’
of OL differentiation. As in stem cells, LIF may induce HDACs that
deacetylate histones associated with gene loci that inhibit
oligodendrocyte differentiation. Deacetylation leads to chromatin
compaction which prevents DNA demethylation and thus the tran-
scription of genes that inhibit myelination
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absent at embryonic day 15.5, and markers of differentiated
oligodendrocytes were absent from postnatal day 4 (Ye
et al. 2009). In addition, primary cortical oligodendrocyte
precursors underwent differentiation arrest when cultured
in vitro (Ye et al. 2009). As Li et al. show, HDAC1 and
HDAC2 are critical for optimal oligodendrocyte specifi-
cation and differentiation (Li and Richardson 2009). These
HDACs were associated with transcriptional control
regions believed to inhibit oligodendrocyte myelination.
Furthermore, the expression of these inhibitory genes
decreased in line with HDAC activity (Shen et al. 2008).
Interestingly, chromatin is predominantly acetylated in
primary oligodendrocyte progenitors whereas it grossly
deacetylates during differentiation (Shen et al. 2005; Liu
et al. 2007; Marin-Husstege et al. 2002). Indeed treatment
with HDAC inhibitors arrests maturation (Shen et al. 2005;
Liu et al. 2007; Marin-Husstege et al. 2002). These studies
support Emery’s ‘de-repression’ theory which argues that
environmental cues e.g. inflammation prompts the attenu-
ation of inhibitors of differentiation, which in this context
is open chromatin and demethylated DNA (Fig. 1) (Emery
2010).
LIF is well known for its function in maintaining the
pluripotency of embryonic stem cells. This occurs through
the Janus kinase/signal transducer and activator of tran-
scription 3 (Jak/Stat3) pathway. McCool et al. showed that
withdrawal of LIF leads to a global increase in histone
acetylation that mimicked the effect of trichostatin A, a
histone deacetylase inhibitor (McCool et al. 2007). These
data could suggest that LIF-induced STAT3 regulates the
action of epigenetic modifiers which control access to
important genes (Fig. 1). These effects fit with the pattern
of HDAC levels required to mediate (re)myelination and
this may in part, explain LIF’s promyelinating effects.
Yamamura et al. showed that FK228 (a HDAC inhibitor)
suppresses the anti-apoptotic effects of EPO on erythroid
precursor cells (Yamamura et al. 2006). The authors
speculated that HDAC inhibition may block an EPO sig-
nalling pathway, indicating that EPO induces HDACs.
Again, given EPO’s capacity to promote oligodendrocyte
differentiation, we postulate that, as in erythrocytes, EPO
may induce HDACs to attenuate inhibitors of myelin gene
expression. In addition, Ye et al. showed that HDAC1 and
HDAC2 stimulate oligodendrocyte differentiation by
directly antagonizing the inhibitory action of Wnt sig-
nalling (Ye et al. 2009).
Conclusion
Epigenetic processes clearly influence the outcome of
(re)myelination. Histone deacetylation is associated with
the repression of important inhibitors of oligodendrocyte
differentiation and neurotrophic cytokines such as LIF and
EPO have demonstrated a potential to induce these HDACs
in other systems. Future research should specifically
examine the epigenetic processes that occur downstream of
LIF and EPO in oligodendrocytes. This could lead to a
novel therapeutic approach to demyelinating disease that
incorporates epigenetic drug targets e.g. HDACs to bolster
the efficacy of exogenous cytokine therapy.
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